Literature DB >> 2265404

Chromosomal changes in thyroid tumors. Relation with DNA content, karyotypic features, and clinical data.

J R Teyssier1, F Liautaud-Roger, D Ferre, M Patey, J Dufer.   

Abstract

A cytogenetic study was performed in 63 thyroid tumors after a monolayer short-term culture. Clonal chromosomal changes were found in 47% of carcinomas and 31% of adenomas. Chromosome 7 was altered in 40% of cytogenetically abnormal tumors. The modal DNA index measured in 26 tumors was consistent with the chromosomal mode in 88% of cases. A quantitative morphometric analysis of nuclear features differentiated between diploid thyroid adenomas with or without a single translocation, which suggests that they have different biological properties. Clonal chromosomal changes were observed in 78% of carcinomas with an aggressive behavior, but only 28% of those had no risk factors. The two patients who died early had abnormalities of chromosome 7.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2265404     DOI: 10.1016/0165-4608(90)90184-c

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  10 in total

1.  BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization.

Authors:  Raffaele Ciampi; Zhaowen Zhu; Yuri E Nikiforov
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

Authors:  S Knuutila; M L Larramendy; P Elfving; W el-Rifai; A Miettinen; F Mitelman
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

3.  DNA copy number changes in thyroid carcinoma.

Authors:  S Hemmer; V M Wasenius; S Knuutila; K Franssila; H Joensuu
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.

Authors:  M A Herrmann; I D Hay; D H Bartelt; S R Ritland; R J Dahl; C S Grant; R B Jenkins
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

5.  Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells.

Authors:  Timothy F Burns; Peiwen Fei; Kimberly A Scata; David T Dicker; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

6.  A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors.

Authors:  G Belge; B Thode; V Rippe; S Bartnitzke; J Bullerdiek
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

7.  Detection of numerical alterations for chromosomes 7 and 12 in benign thyroid lesions by in situ hybridization. Histological implications.

Authors:  B Criado; A Barros; R F Suijkerbuijk; D O Weghuis; R Seruca; E Fonseca; S Castedo
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

8.  Genetic and biological subgroups of low-stage follicular thyroid cancer.

Authors:  Christopher A French; Erik K Alexander; Edmund S Cibas; Vania Nose; Julia Laguette; William Faquin; Jeff Garber; Francis Moore; Jonathan A Fletcher; P Reed Larsen; Todd G Kroll
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

9.  RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.

Authors:  Rozita Bagheri-Yarmand; Naifa L Busaidy; Elena McBeath; Brian P Danysh; Kurt W Evans; Tyler J Moss; Argun Akcakanat; Patrick K S Ng; Christina M Knippler; Jalyn A Golden; Michelle D Williams; Asha S Multani; Maria E Cabanillas; Kenna R Shaw; Funda Meric-Bernstam; Manisha H Shah; Matthew D Ringel; Marie Claude Hofmann
Journal:  Cancers (Basel)       Date:  2021-09-30       Impact factor: 6.575

10.  Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.

Authors:  S Hemmer; V M Wasenius; S Knuutila; H Joensuu; K Franssila
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.